Correction: Global economic cost of smoking-attributable diseases (Tobacco Control (2018) 27 (58-64) DOI: 10.1136/tobaccocontrol-2016-053305);Global economic cost of smoking-attributable diseases

Tobacco Control

Volumn 27, Issue 1, 2018, Pages 58-64

  Goodchild, Mark ^a   Nargis, Nigar ^b   D’Espaignet, Edouard Tursan ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b AMERICAN CANCER SOCIETY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST OF ILLNESS; DEVELOPING COUNTRY; ECONOMICS; GLOBAL HEALTH; HEALTH CARE COST; HUMAN; PRODUCTIVITY; SMOKING; STATISTICS AND NUMERICAL DATA;

COST OF ILLNESS; DEVELOPING COUNTRIES; EFFICIENCY; GLOBAL HEALTH; HEALTH CARE COSTS; HEALTH EXPENDITURES; HUMANS; SMOKING;

EID: 85012030401     PISSN: 09644563     EISSN: 14683318     Source Type: Journal    
DOI: 10.1136/tobaccocontrol-2016-053305corr1     Document Type: Erratum

References (57)

1. USDHHS. The health consequences of smoking: a report to the Surgeon General. Washington DC, US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2004.
2. Murray CJL, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: Global burden of disease study. Lancet 1997;349:1498–15.
3. WHO. Economics of tobacco toolkit: assessment of the economic costs of smoking. Geneva, World Health Organization, 2011.
4. UN. Political Declaration of the High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases. New York: United Nations General Assembly, 2012.
5. UN. Transforming our World: the 2030 Agenda for Sustainable Development. New York: United National General Assembly, 2015.
6. WHO. Health in 2015: from MDGs, Millennium Development Goals to SDGs, Sustainable Development Goals. Geneva: World Health Organization, 2015.
7. WHO. WHO framework convention on tobacco control. Geneva: World Health Organization, 2003.
8. WHO. WHO report on the global tobacco epidemic, 2015: raising taxes on tobacco. Geneva: World Health Organization, 2015.
9. WHO. WHO report on the global tobacco epidemic 2008: the MPOWER package. Geneva: World Health Organization, 2008.
10. WHO & WEF. From burden to “best buys": reducing the economic impact of NCDs in low- and middle-income countries. Geneva: World Health Organization & World Economic Forum, 2011.
11. WHO. WHO guide to identifying the economic consequences of disease and injury. Geneva: World Health Organization, 2009.
12. Guindon E, Tobin P, Lim M, et al. The costs attributable to tobacco use: a critical review of the literature. Geneva: World Health Organization, 2007.
13. World Bank. What is purchasing power parity? Washington DC: International Comparison Programme, World Bank, 2012.
14. Cadilhac DA, Magnus A, Sheppard L, et al. The societal benefits of reducing six behavioural risk factors: an economic modelling study from Australia. BMC Public Health 2011;11:483.
15. Collins D, Lapsley H. The costs of tobacco, alcohol and illicit drug abuse to Australian society in 2004/05. Canberra: Commonwealth of Australia, 2008.
16. GHK. A study on liability and the health costs of smoking. London, GHK, 2009.
17. WHO. Impact of tobacco-related illnesses in Bangladesh. Dhaka: World Health Organization, 2005.
18. Pinto M, Pichon-Riviere A, Bardach A. The burden of smoking-related diseases in Brazil: mortality, morbidity and costs. Cad. Saude Publica 2015;31:1283–97. http://dx.doi.org/10.1590/0102–311X00192013
19. Rehm K, Baliunas D, Brochu S, et al. The costs of substance abuse in Canada. Ontario: Canadian Centre on Substance Abuse, 2006.
20. Sung HY, Wang L, Jin S, et al. Economic burden of smoking in China, 2000. Tob Control 2006;15(Suppl I):i5–i11.
21. Yang L, Sung HY, Mao Z, et al. Economic Costs Attributable to Smoking in China: update and an 8-year Comparison, 2000–2008. Tob Control. 2011;20:266–72.
22. Sovinová H, Csémy L, Procházka B, et al. Smoking attributable hospital treatment, treatment costs and smoking attributable mortality in the Czech Republic in 2002. Cent Eur J Public Health 2007;15:79–83.
23. Rasmussen SR, Prescott E, Sorensen TI, et al. The total lifetime cost of smoking. Eur J Public Helath 2004;14:95–100.
24. Taal A, Kiivet R, Hu T. The economics of tobacco in Estonia. Health, nutrition and population discussion paper series, economics of tobacco control paper no. 19. Washington DC: World Bank, 2004.
25. Neubauer S, Welte R, Beiche A, et al. Mortality, morbidity and costs attributbale to smoking in Germany: update and a 10-year comparison. Tob Control. 2006;15:464–71.
26. Ruff LK, Volmer T, Nowak D, et al. The economic impact of smoking in Germany. Eur Respir J 2000;16:385–90.
27. Welte R, Koing H, Leidl R. The costs of health damage and productivity losses attributable to cigarette smoking in Germany. Tob Control 1999;8:290–300.
28. John RM, Sung HY, Max W. Economic cost of tobacco use in India, 2004. Tob Control 2009;18:138–43.
29. John R, Rout S, Kumar B, et al. Economic burden of tobacco-related diseases in India. New Delhi: Ministry of Health and Family Welfare, Government of India, 2015.
30. Ginsberg G, Geva H. The burden of smoking in Israel–attributable mortality and costs—2014. Israel J Health Policy Res 2014;3:28.
31. Izumi Y, Tsuji I, Ohkubo T, et al. Impact of smoking habit on medical care use and its costs: a prospective observation of National Health Insurance beneficiaries in Japan. In J Epidemiol 2001;30:616–21.
32. Chaaban J, Naamani N, Salti N. The economics of tobacco in Lebanon: an estimation of the social costs of tobacco consumption. Beirut: American University in Beirut Tobacco Control Research Group, 2010.
33. Reynales-Shigematsu LM, Rodríguez-Bolaños RL, Jimenez JA, et al. Health care costs attributable to tobacco consumption on a national level in the Mexican Social Security Institute. Salud Pública Méx 2006;48(Suppl 1):S48–64. Spanish.
34. van Genugten ML, Hoogenveen RT, Mulder I, et al. Future burden and costs of smoking-related disease in the Netherlands: a dynamic modeling approach. Value Health 2003;6:494–9.
35. Potapchik E, Popovich L. Social cost of substance abuse in Russia. Value in Health Regional 2014;4:1–5. http://dx.doi.org/10.1016/j.vhri.2014.03.004
36. Quah E, Tan KC, Saw SL, et al. The social cost of smoking in Singapore. Singapore Med J 2002;43:340–4.
37. Kang HY, Kim HJ, Park TK, et al. Economic burden of smoking in Korea. Tob Control 2003;12:37–44.
38. Bolin K, Borgman B, Gip C, et al. Current and future avoidable cost of smoking—estimates for Sweden 2007. Health Policy 2011;103:81–91.
39. Priez F, Jeanrenaud C, Vitale S, et al. The social cost of tobacco in Switzerland. Switzerland: IRER—University of Neuchâtel, 1999.
40. Leartsakulpanitch J, Nganthavee W, Salole E. The economic burden of smoking-related disease in Thailand: a prevalence-based analysis. J Med Assoc Thai 2007;90:9.
41. Allender S, Balakrishnan R, Scarborough P, et al. The burden of smoking-related ill health in the UK. Tob Control 2009;18:262–7.
42. Scarborough P, Bhatnagar P, Wickramasinghe K, et al. The economic burden of ill health due to diet, physical inactivity, smoking, alcohol and obesity in the UK: an update to 2006–07 NHS costs. J Public Health 2011;33:527–35.
43. Centers for Disease Control and Prevention (CDC). Annual smoking-attributable mortality, years of potential life lost, and economic costs--United States, 1995–1999. MMWR Morb Mortal Wkly Rep 2002;51:300–3.
44. Xu X, Bishop EE, Kennedy SM, et al. Annual Healthcare Spending Attributable to Cigarette Smoking—an update. Am J Prev Med 2015;48:326–33.
45. Hoang Anh P, Thu L, Ross H, et al. Direct and indirect costs of smoking in Vietnam. Tob Control 2014;0:1–5.
46. Ross H, Vu Trung D, Xuan Phu V. The cost of smoking in Vietnam: the case of inpatient care. Tob C ontrol 2007;16:405–9.
47. WHO. WHO global report: mortality attributable to tobacco. Geneva: World Health Organization, 2012.
48. WHO Global Health Expenditure database accessed online 1 September 2015. http://www.who.int/gho/health_financing/en/
49. Peto R, Lopez AD, Boreham J, et al. Mortality from tobacco in developing countries: indirect estimation from national vital statistics. Lancet 1992;339:1268–78.
50. WHO Global Burden of Disease data accessed online 8 May 2015. http://www.who.int/healthinfo/global_burden_disease/en/
51. World Bank Group World Development Indicators data accessed online 25 May 2015. http://data.worldbank.org/products/wdi
52. IMF World Economic Outlook April 2015 update accessed online 25 May 2015. http://www.imf.org/external/pubs/ft/weo/2015/01/weodata/index.aspx
53. WHO. WHO guide to cost effectiveness analysis. Geneva: World Health Organization, 2003.
54. Oberg M, Jaakkola MS, Woodward A, et al. Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries. Lancet 2011;377:139–46.
55. Feirman SP, Glasser AM, Teplitskaya L, et al. Medical costs and quality-adjusted life years associated with smoking: a systematic review. BMC Public Health 2016;16:646.
56. Koopmanschap MA, Rutten FF, van Ineveld BM, et al. The friction cost method for measuring indirect costs of disease. J Health Econ 1995;14:171–89.
57. Viscusi W, Aldy J. The Value of a Statistical Life: A Critical Review of Market Estimates Throughout the World. Harvard Law School John M. Olin Center for Law, Economics and Business Discussion Paper Series. Paper 392.